Action of natural killer cells and macrophages in cancer
β Scribed by Eva Klein; Alberto Mantovani
- Publisher
- Elsevier Science
- Year
- 1993
- Tongue
- English
- Weight
- 567 KB
- Volume
- 5
- Category
- Article
- ISSN
- 0952-7915
No coin nor oath required. For personal study only.
β¦ Synopsis
According
to the results obtained in several types of experiments the immunological anti-tumor effects that reflect the clinical situation involve T lymphocytes.
The products of natural effector cells can contribute to anti-tumor immunity as part of the cytokine network.
In addition, some cytokines can act on the tumor cells by influencing directly their proliferative capacity and/or through modification of their phenotype. In the tumor tissue the interaction between malignant cells and host cells on the one hand, and between the various types of host cells on the other hand, is complex. The participating mechanisms can act in both directions, with the result that the outcome of the balance may be either inhibition or stimulation of tumor growth.
π SIMILAR VOLUMES
## Background: In a group of patients with head and neck cancers (h&nc), the expansion of the population of cd3-,cd16+ natural killer (nk) cells in the peripheral blood was studied. ## Methods: Cytofluorimetric analysis of the expression of killer ig-like receptors (kir, namely p58.1, p58.2, p58.
## Abstract A series of monosaccharides were tested for their ability to inhibit the effector phase of macrophageβmediated cytolysis against two susceptible murine tumor target cells, L5I78Y and RLβI. Two monosaccharides, Dβmannose and __N__βacetylβDβgalactosamine, were found to decrease cytotoxici